| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 07/08/2004 | US20040133099 Diagnosis or prophylaxis of ear disorders comprising transporting nanostructure particles conjugated with lipids, proteins, animal growth regulators, hormones, antioxidants, free radical scavengers, steroids or drugs, into ears |
| 07/08/2004 | US20040131687 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 07/08/2004 | US20040131587 Administering mixture of dendritic cells, apoptosis or necrosis agents,chemattractants |
| 07/08/2004 | US20040131547 Contrast agents |
| 07/08/2004 | US20040131497 Process for sterilization of biological compositions containg protein |
| 07/07/2004 | EP0918519B1 Therapeutic treatment for vegf related occular diseases |
| 07/07/2004 | EP0825851B1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 07/06/2004 | US6759403 Metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 07/01/2004 | WO2004026111A3 Flexible and/or elastic brachytherapy seed or strand |
| 07/01/2004 | US20040127539 Antiangiogenic combination therapy for the treatment of cancer |
| 07/01/2004 | US20040127470 Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| 07/01/2004 | US20040127428 Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures |
| 07/01/2004 | US20040127425 Control of nitric oxide bioactivity by perfluorocarbons |
| 06/30/2004 | EP0996465B1 Compositions and articles for reducing the effects of inflammation |
| 06/30/2004 | CN1509188A Immunoconjugates made of egg-yolk antibiodies (IGY), production and use thereof in diagnoses and therapy |
| 06/29/2004 | US6756396 Ethylene glycol esters as photoactive agents |
| 06/24/2004 | WO2004052407A1 Ultrasound contrast using halogenated xanthenes |
| 06/24/2004 | US20040122492 Phototherapeutic treatment of skin conditions |
| 06/24/2004 | US20040122491 Reduced fluence rate PDT |
| 06/24/2004 | US20040122011 such as 3-[3-[N-isopropyl-N-(4-methoxyphenyl-sulfonyl)amino]-phenyl]-3-(3-pyridyl)-2(E)-propenohydroxamic acid; for treatment/prevention of neoplasia/inflammation; kits |
| 06/24/2004 | US20040120935 Genetically modified yt cell line and use thereof |
| 06/24/2004 | US20040120893 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
| 06/24/2004 | CA2505975A1 Ultrasound contrast using halogenated xanthenes |
| 06/23/2004 | EP1429758A1 Photodynamic porphyrin antimicrobial agents |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1089767B1 Method of inactivating viruses |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/17/2004 | WO2004024144A9 Method of treating skin disorders |
| 06/17/2004 | US20040116385 bound to carboranyl groups; kills or inhibits the human immunodeficiency virus |
| 06/17/2004 | US20040115433 Mixture of hydrophobic polymer core and nanoparticles; immobilization |
| 06/17/2004 | US20040115129 Nucleic acid sequence 1 or 3; amino acid sequence 2 or 4 |
| 06/17/2004 | DE10255217A1 Homeopathic medicament for treating mental suffering conditions, e.g. grief, comprising tears subjected to homeopathic dilution and incorporated in dosage form |
| 06/16/2004 | EP1427813A2 Method for dendritic cells-based immunotherapy of tumors using combination therapy |
| 06/16/2004 | EP1427712A2 Dye-azide compounds for dual phototherapy |
| 06/16/2004 | EP1427482A2 Method and apparatus for acne treatment |
| 06/16/2004 | EP1427462A1 Method for inducing selectively suppressed immune response |
| 06/16/2004 | EP1171140B1 Treatment of hypersensitivity reaction disorders |
| 06/15/2004 | US6750212 Photochemotherapeutic compositions |
| 06/15/2004 | US6749851 Applying radiation |
| 06/10/2004 | WO2004047821A1 Methods for preventing phototoxic damage during photodynamic therapy |
| 06/10/2004 | WO2004013307A3 Compounds for targeting hepatocytes |
| 06/10/2004 | WO2003087307A3 Use of interleukin-19 to treat cervical cancer |
| 06/10/2004 | US20040110846 Perylenequinones for use with immunotherapy agents |
| 06/10/2004 | US20040110819 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 06/10/2004 | US20040110818 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 06/10/2004 | US20040110764 Inhibit oncogene Ras; treating neurofibromin benign proliferative disorder; cancer (combination therapy); blindness, hepatitis infection, restenosis, polycystic kidney disease; imidazo[2,1-b]thiazole derivatives for example |
| 06/10/2004 | US20040110739 Administering precursor of protoporphyrin IX; accumulating therapeutic levels of protoporphyrin IX; photoactivation with light; detecting and treating high speed growth exogenous cells, such as Protista, or parasites |
| 06/10/2004 | US20040110731 Photodynamic therapy for the treatment of non-melanoma skin cancer |
| 06/10/2004 | US20040109903 Method for extended storage of viable and pathogen-safe blood and blood components using carbon monoxide |
| 06/10/2004 | US20040109823 Flexible and/or elastic brachytherapy seed or strand |
| 06/09/2004 | EP1424942A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| 06/09/2004 | DE10254359A1 Apparatus used for energy transfer from crystals to foods or materials for external applications comprises container with crystal in or on container wall |
| 06/09/2004 | CN1152716C Farnesyl protein transferase inhbitors with internal radiosensitizing |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6746696 Triterpene compositions and methods for use thereof |
| 06/08/2004 | US6746663 Porphyrin compounds |
| 06/08/2004 | US6746661 Biocompatible component, therapeutically active component comprising a non-radioactive drug, and a radiopaque marker; seed has a size and shape suitable for passing through the bore of a 10 gauge needle |
| 06/08/2004 | CA2133741C Photochemotherapeutic method using 5-aminolevulinic acid and precursor thereof |
| 06/04/2004 | CA2414721A1 Photodynamic therapy for the treatment of non-melanoma skin cancer |
| 06/03/2004 | WO2004045652A2 Biocompatible magnetic materials for the treatment of cancer by means of hyperthermia, and processes for their production |
| 06/03/2004 | US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/02/2004 | EP1423120A1 2h-phthalazin-1-ones and methods for use thereof |
| 06/02/2004 | EP1330514B1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 06/01/2004 | US6743779 Methods for delivering compounds into a cell |
| 05/27/2004 | WO2004044149A2 Method for suppressing immune system response to transplanted tissue or cells |
| 05/27/2004 | WO2004043338A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/27/2004 | US20040102430 Drug delivery systems for photodynamic therapy |
| 05/27/2004 | US20040102383 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 05/27/2004 | US20040102360 Combination therapy |
| 05/27/2004 | US20040101564 Embolization |
| 05/27/2004 | US20040101517 Central nervous system diosrders; Alzheimer's disease; Parkinson's disease; regeneration normal endothelial function; applying oxidation stresses to cells; angiotensin receptor antagonist |
| 05/27/2004 | CA2492103A1 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/26/2004 | EP1420824A2 Compound |
| 05/26/2004 | EP1420770A1 Photoreactive compounds and compositions |
| 05/26/2004 | EP1149057B1 Biodegradable glass compositions and their use in the manufacture of a medicament for radiation therapy |
| 05/26/2004 | EP0971710B1 Use of chelerythrine and radiation for tumor therapy |
| 05/25/2004 | US6740637 Photodynamic therapy (pdt) photosensitizers; tumor diagnosis; conjugation with cell-specific ligands, target the tumor site; melanocyte stimulating hormones conjugates are suitable for pdt of melanoma tumors |
| 05/21/2004 | WO2004041314A1 Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells |
| 05/21/2004 | WO2004041307A2 Compositions and methods for treating cancer using cytotoxic cd44 antibody immunoconjugates and radiotherapy |
| 05/21/2004 | WO2003103569A3 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 05/21/2004 | WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 05/21/2004 | WO2002083686B1 Processes for large scale production of tetrapyrroles |
| 05/21/2004 | CA2504585A1 Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/19/2004 | EP1418932A1 An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 05/19/2004 | CN1149978C Quinolone-containing liposome composition and their preparation method |
| 05/18/2004 | US6736979 Neutralize or prevent the growth of and/or remove a certain number of undifferentiated animal cells, tumor cells, algae, bacteria or viruses from a sample with high-frequency ultrasound emission |
| 05/13/2004 | US20040092907 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 05/13/2004 | US20040092586 Oxidation resistance; aging resistance; skin disorders |
| 05/13/2004 | US20040092557 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/13/2004 | US20040091541 Solid matrix therapeutic compositions |
| 05/13/2004 | US20040091463 Sensitization of neoplastic cells to radiation therapy with reovirus |
| 05/13/2004 | US20040091421 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 05/13/2004 | DE19646762B4 Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren Use of metal compounds for preparing compositions for radiotherapy of tumors |
| 05/12/2004 | EP1417974A1 Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy |
| 05/12/2004 | EP1416974A1 Gas microsphere liposome composites |
| 05/12/2004 | EP1416970A2 Conjugate |
| 05/12/2004 | EP1416960A1 Vegfr-1 antibodies to treat breast cancer |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | CN1149101C Green porphyrins as immunomodulators |